In several case reports, risperidone has shown efficacy in treating flashbacks and other intrusive symptoms that relate to traumatic events, as well as in treating irritable aggression (5) (6) (7) (8) . One controlled study with risperidone targeted psychotic features in combat veterans with chronic PTSD. In this trial, positive and negative psychotic symptoms improved, compared with the placebo group, but core PTSD symptoms measured by total Clinician Administered PTSD Scale (CAPS) score did not differ from those in the placebo group (9) .
Another small controlled trial with olanzapine (15 civilians randomized to monotherapy or placebo), did not differentiate the active drug from the placebo, although an open-label study suggested benefits for olanzapine in 48 veterans with chronic PTSD (10, 11) . In this last study, however, one-third of subjects failed to complete the trial, largely because of adverse events or noncompliance (11) .
A case report found clozapine useful in a treatment-refractory patient with combat-associated PTSD and psychosis (12) .
With respect to using quetiapine as an adjunctive treatment, Hamner and others completed an open-label trial in 20 refractory patients with PTSD, and the results are encouraging. The average dosage of quetiapine was 100 mg daily, with a range of 25 mg to 300 mg daily. Patients experienced improved sleep and a reduction in the frequency and intensity of nightmares. The total CAPS rating and the symptom clusters were also significantly improved by quetiapine (13) .
In our experience, quetiapine adjunctive treatment has reduced flashbacks in 5 chronically affected PTSD patientsflashbacks being one of the core and most painful symptoms in PTSD.
Use of quetiapine as adjunctive treatment and monotherapy for PTSD needs assessment in well-designed clinical trials with larger samples, because it may represent an interesting treatment option in PTSD.
Marie-Josée Filteau, MD, FRCPC; Jacinthe Leblanc, Pharm, BCPP; Roch-Hugo Bouchard, MD, FRCPC Quebec City, Quebec
Behaviour Therapy for Dizziness?
A woman in her mid-30s presented with recurrent, unexplained dizziness. Two years prior to presentation, she had a 3-to 4-hour period of dizziness, nausea, and vomiting. She saw her family doctor and was told that she had a viral illness, but since then, she has become fearful of further episodes of dizziness. When she felt dizzy, she immobilized her head and neck for several hours until the feeling of dizziness disappeared. She saw numerous physicians who performed many investigations to rule out medical conditions. She was quite distressed about these episodes and had significant anticipatory anxiety with respect to the dizziness. She had decreased functioning at her work because of dizziness. However, she did not meet criteria for panic attacks. Otherwise, she was healthy and had no other psychiatric or medical comorbidity. She did not take any medications. There was no family history of anxiety problems.
The diagnosis of limited-symptom panic disorder was the best explanation for this presentation. Although pharmacotherapy (that is, a serotonin reuptake inhibitor [SRI]) was considered, this treatment modality was avoided, owing to the sensitivity of patients with panic disorder to side effects of antidepressants and to this woman's limited-symptom panic attacks.
She was treated with 4 individual sessions, using exposure and response prevention. In the first 2 sessions, it was explained to the patient that she had developed fear of the dizziness sensation through classic conditioning. The more she tried to avoid the sensation, the more sensitive she had become to any head movement that resulted in slight dizziness sensations. She was asked to gradually expose herself to the dizziness sensation by spinning around for 30 to 60 seconds daily. She responded well to the systematic desensitization, with no further episodes of dizziness. She was followed for 6 months and maintained her improvement.
Dizziness that is unrelated to a medical condition is a common problem in the population (1-3) and is associated with significant disability and high rates of medical services use (4, 5) . Recent studies have demonstrated that a significant proportion of persons with unexplained dizziness have an underlying anxiety disorder diagnosis (6, 7) . Recognition and treatment of this problem is likely to reduce disability and costs to society. A recent open-label trial confirmed that most people with psychogenic dizziness respond to treatment with an SRI antidepressant (8) . Of the sample in this study, however, 25% stopped the antidepressant because of adverse effects (8) . With respect to nonpharmacologic strategies, data support behaviour therapy and vestibular rehabilitation as similar and effective in treating psychiatric dizziness (9) (10) (11) . The problem with cognitivebehavioural therapy is the lack of availability of trained clinicians to conduct this treatment.
This case highlights 2 important issues: 1) individuals presenting with dizziness who do not meet the full criteria for panic attacks may be underrecognized and undertreated or delayed in receiving treatment, and 2) the feasibility of applying brief behavioural interventions in primary care and otolaryngology clinics should be further explored (12) .
Paper previously presented at the Canadian Psychiatric Association Annual Meeting; October 2002; Banff (AB).
Jitender Sareen BSc, MD, FRCPC Winnipeg, Manitoba

Involuntary Treatment of a Patient with Factitious Disorder: A Paradox?
Dear Editor:
We recently undertook a chart review on a challenging patient. Aside from the statistical aspects, the review shed light on the factitious component of her presentation. We report an uncommon approach to the management of this patient, whose factitious disorder compromises the treatment of her bona fide illnesses: long-term involuntary inpatient treatment.
Case Report
FD is a 35-year-old single, childless white woman on social assistance. Her extensive psychiatric history began at age 14 years with the diagnosis of panic disorder. Anorexia nervosa was diagnosed 2 years later but soon revised to bulimia nervosa. At age 17 years, bipolar affective disorder type I was added. FD also engages in polydipsia, consuming as much as 84 cans of cola during a weekend. This has been manifested independently of bulimia. A borderline level of integration underlies her histrionic and narcissistic behaviour.
FD's family is highly enmeshed. Her father retired early from farming, owing to his rheumatoid arthritis and his struggle with alcoholism. Her mother was a nurse and worked night shifts so she could "babysit" FD's father. Prestigious awards for academic brilliance and ballet dancing marked FD's early development. However, she pursued high marks as an end. FD once admitted that, in Grade 3, she injured her foot deliberately to be excused from a rare slip in her marks. Corresponding documentation indicates that the orthopedic surgeon found FD had changing symptoms, which he attributed to chronic ankle strain. She was unable to complete the second year of university or maintain employment for more than a few months. Clinical records aside, FD's charts are littered with writings that discuss her engrossment with the pursuit of youth, beauty, and prestige. They reflect frequent resort to denial, to acting out, to externalization, and to intellectualization, as well as to erotic transference to male psychiatrists. Subtle suggestions of deception abound. In fact, in one letter, she detailed reasons for maintaining her bulimia, one of which was the freedom from responsibility.
Her medical records show 91 hospitalizations between 1981 and 2001. FD was certified for at least part of 30 admissions. There were numerous examples of noncompliance and of premature discharges against medical advice, many of which were facilitated by her mother. Hospital fees alone totalled $1.6 million, overshadowing the costs of other health care use, including her 175 emergency room visits that did not lead to admission. Inconsistencies on several levels insinuate a factitious component in FD's presentation: 1) her frequent calls for attention to her symptoms contrast sharply with her habitual defences; 2) rarely does one encounter a patient with bulimia who frequents the emergency room demanding specific blood work and intravenous therapy; and most informative, 3) mental status examinations contradicted her complaints on many occasions.
It seems paradoxical to apply long-term certification in treating a patient with factitious disorder. FD's case, however, is complicated by comorbidity with Axis I diagnoses. Periods of relative stability followed previous involuntary hospitalizations. Lasting gains are likely possible only in a setting where her treatment cannot be sabotaged by her impulsivity and her mother's interference. The outcome remains to be evaluated. Bienca Lau, Resident Saskatoon, Saskatchewan Eugene Marcoux, Consultant Saskatoon, Saskatchewan
